|
Volumn 8, Issue 4, 2004, Pages 213-219
|
Safety and efficacy of tacrolimus ointment 0.1% (Protopic™) in atopic dermatitis: A Canadian open-label multicenter study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TACROLIMUS;
ADOLESCENT;
ARTICLE;
ATOPIC DERMATITIS;
BACTERIAL ARTHRITIS;
BODY SURFACE;
BURNING SENSATION;
CELLULITIS;
CHICKENPOX;
CHILD;
CLINICAL TRIAL;
CONDYLOMA ACUMINATUM;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ECZEMA;
FEMALE;
FLU LIKE SYNDROME;
FOLLICULITIS;
HEADACHE;
HERPES SIMPLEX;
HUMAN;
IMPETIGO;
INFLUENZA;
MAJOR CLINICAL STUDY;
MALE;
MOLLUSCUM CONTAGIOSUM;
MULTICENTER STUDY;
MYCOSIS;
NAIL INFECTION;
PHARYNGITIS;
PITYRIASIS ROSEA;
PRIORITY JOURNAL;
PRURITUS;
PUSTULE;
RHINOPHARYNGITIS;
SCORING SYSTEM;
SIDE EFFECT;
SKIN INFECTION;
STATISTICAL SIGNIFICANCE;
SWEATING;
TINEA PEDIS;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
DERMATITIS, ATOPIC;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
OINTMENTS;
TACROLIMUS;
TREATMENT OUTCOME;
|
EID: 24044544595
PISSN: 12034754
EISSN: None
Source Type: Journal
DOI: 10.1007/s10227-003-0115-z Document Type: Article |
Times cited : (13)
|
References (9)
|